• EZZ enters 4-year global distribution deal with Aumake
• Minimum purchase commitments of A$10 million over initial term
• Aumake appointed exclusive global distributor across all channels

EZZ Life Science Holdings (ASX: EZZ) has announced that it has entered into a four-year global distribution agreement with Aumake Limited (ASX:AUK) for the distribution and sale of exclusive co-developed EZZ-branded products. Under the agreement, Aumake has been appointed as the exclusive global distributor across all sales channels for the covered products. The initial term of the agreement is four years, commencing in February 2026, with automatic renewal periods subject to performance and termination provisions. The agreement includes minimum aggregate purchase commitments of A$10 million over the initial four-year term, with minimum annual purchase commitments of A$2.5 million per contract year. Failure to meet the minimum annual purchase thresholds may result in the termination of Aumake's exclusive distribution rights. Aumake will be responsible for executing sales and distribution activities globally in accordance with EZZ's product specifications, brand guidelines, and operational standards. EZZ retains ownership of all intellectual property and maintains oversight of product integrity, branding, and compliance. This agreement aligns with EZZ's strategy to expand global distribution through established platforms and channels, while maintaining disciplined capital allocation and brand control.

The appointment of Aumake as an exclusive global distributor represents an important step in expanding EZZ's international distribution capability. Aumake's established infrastructure and platform experience provide an opportunity to scale selected EZZ products across global channels, while maintaining EZZ's focus on brand integrity and product quality.